Valon Lasers main products, 532nm pattern scanning photocoagulators Valon 5G and Valon TT, are developed mainly for treatment of diabetic retinopathy – a major cause for blindness in developed countries if left untreated. Valon Lasers has crafted ophthalmic lasers during five decades, a legacy few ophthalmic laser companies can match. In the VALON multispot laser they have combined decades of experience and knowledge with the newest technology to provide solutions for discerning ophthalmologists. All the development and production work is crafted in Vantaa, Finland at Valon Lasers’ headquarters.
Meridian acquired Valon Lasers in 2019.